Patents by Inventor Lars Prestegarden

Lars Prestegarden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING A PEPTIDE
    Publication number: 20210154268
    Abstract: The present invention relates to a method of treating neoplastic conditions, particularly cancers, comprising the administration to a subject of a combination of an oligopeptidic compound comprising the amino acid sequence set forth in SEQ ID NO: 1, or an amino acid sequence having at least 85% sequence identity thereto, and a checkpoint inhibitor.
    Type: Application
    Filed: June 19, 2019
    Publication date: May 27, 2021
    Inventor: Lars PRESTEGARDEN
  • Oligopeptide compounds and uses thereof
    Patent number: 9353156
    Abstract: The present invention relates to novel agents, pharmaceutical compositions containing them, and their use in therapy, particularly anti-microbial and anti-cancer therapy. In particular, the present invention relates to novel peptide-based compounds based on SEQ ID NO: 40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells, particularly bacterial and cancer cells. Also provided are therapeutic and non-therapeutic methods which include the use of peptides of the invention.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 31, 2016
    Assignee: Cytovation AS
    Inventor: Lars Prestegarden
  • OLIGOPEPTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20150038407
    Abstract: The present invention relates to novel agents, pharmaceutical compositions containing them, and theft use in therapy, particularly anti-microbial and anti-cancer therapy. In particular, the present invention relates to novel peptide-based compounds based on SEQ ID NO: 40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells, particularly bacterial and cancer cells. Also provided are therapeutic and non-therapeutic methods which include the use of peptides of the invention.
    Type: Application
    Filed: June 16, 2014
    Publication date: February 5, 2015
    Inventor: Lars Prestegarden
  • Oligopeptide compounds and uses thereof
    Patent number: 8754042
    Abstract: The present invention relates to novel agents, pharmaceutical compositions containing them, and their use in therapy, particularly anti-microbial and anti-cancer therapy. In particular, the present invention relates to novel peptide-based compounds based on SEQ ID NO:40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells, particularly bacterial and cancer cells. Also provided are therapeutic and non-therapeutic methods which comprise the use of peptides of the invention.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: June 17, 2014
    Assignee: Cytovation AS
    Inventor: Lars Prestegarden
  • OLIGOPEPTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20130023461
    Abstract: The present invention relates to novel agents, pharmaceutical compositions containing them, and their use in therapy, particularly anti-microbial and anti-cancer therapy. In particular, the present invention relates to novel peptide-based compounds based on SEQ ID NO:40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells, particularly bacterial and cancer cells. Also provided are therapeutic and non-therapeutic methods which comprise the use of peptides of the invention.
    Type: Application
    Filed: February 1, 2011
    Publication date: January 24, 2013
    Inventor: Lars Prestegarden